FINEARTS-HF — The Latest Masterpiece for MRAs in Heart Failure | NEJM
Mineralocorticoid receptor antagonists (MRAs) are a cornerstone of treatment for patients with chronic heart failure and reduced ejection fraction. In international guidelines, these agents have a …